Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 155


Infiltrative tumor growth patterns on magnetic resonance imaging associated with systemic inflammation and oncological outcome in patients with high-grade soft-tissue sarcoma.

Nakamura T, Matsumine A, Matsubara T, Asanuma K, Yada Y, Hagi T, Sudo A.

PLoS One. 2017 Jul 20;12(7):e0181787. doi: 10.1371/journal.pone.0181787. eCollection 2017.


[Treatment Strategy for Soft Tissue Sarcomas].

Matsumine A.

Gan To Kagaku Ryoho. 2017 Jun;44(6):452-456. Japanese.


Analysis of Factors for Predicting Survival in Soft-tissue Sarcoma with Metastatic Disease at Initial Presentation.

Nakamura T, Katagiri H, Shido Y, Hamada S, Yamada K, Nagano A, Yamada S, Tsukushi S, Ishimura D, Matsumine A, Sudo A, Nishida Y.

Anticancer Res. 2017 Jun;37(6):3137-3141.


Efficacy of Trabectedin in Patients With Advanced Translocation-Related Sarcomas: Pooled Analysis of Two Phase II Studies.

Takahashi M, Takahashi S, Araki N, Sugiura H, Ueda T, Yonemoto T, Morioka H, Hiraga H, Hiruma T, Kunisada T, Matsumine A, Shimura M, Kawai A.

Oncologist. 2017 May 18. pii: theoncologist.2016-0064. doi: 10.1634/theoncologist.2016-0064. [Epub ahead of print]


Impact of tumor volume doubling time on post-metastatic survival in bone or soft-tissue sarcoma patients treated with metastasectomy and/or radiofrequency ablation of the lung.

Nakamura T, Matsumine A, Takao M, Nakatsuka A, Matsubara T, Asanuma K, Sudo A.

Onco Targets Ther. 2017 Jan 31;10:559-564. doi: 10.2147/OTT.S121562. eCollection 2017.


Analysis of pulmonary nodules in patients with high-grade soft tissue sarcomas.

Nakamura T, Matsumine A, Matsusaka M, Mizumoto K, Mori M, Yoshizaki T, Matsubara T, Asanuma K, Sudo A.

PLoS One. 2017 Feb 9;12(2):e0172148. doi: 10.1371/journal.pone.0172148. eCollection 2017.


Phase 2 study of eribulin in patients with previously treated advanced or metastatic soft tissue sarcoma.

Kawai A, Araki N, Naito Y, Ozaki T, Sugiura H, Yazawa Y, Morioka H, Matsumine A, Saito K, Asami S, Isu K.

Jpn J Clin Oncol. 2017 Feb 1;47(2):137-144. doi: 10.1093/jjco/hyw175.


Ewing Sarcoma of the Bone With EWS/FLI1 Translocation After Successful Treatment of Primary Osteosarcoma.

Yodoya N, Iwamoto S, Matsumine A, Azuma E, Toyoda H, Miura Y, Nakatani K, Imai H, Hirayama M, Komada Y.

J Pediatr Hematol Oncol. 2017 Jan;39(1):6-9.


Neoplastic fever in patients with bone and soft tissue sarcoma.

Nakamura T, Matsumine A, Matsubara T, Asanuma K, Sudo A.

Mol Clin Oncol. 2016 Nov;5(5):631-634. Epub 2016 Sep 21.


STAT3 inhibitor, cucurbitacin I, is a novel therapeutic agent for osteosarcoma.

Oi T, Asanuma K, Matsumine A, Matsubara T, Nakamura T, Iino T, Asanuma Y, Goto M, Okuno K, Kakimoto T, Yada Y, Sudo A.

Int J Oncol. 2016 Dec;49(6):2275-2284. doi: 10.3892/ijo.2016.3757. Epub 2016 Nov 3.


Erratum to: Atypical and malignant granular cell tumors in Japan: a Japanese Musculoskeletal Oncology Group (JMOG) study.

Imanishi J, Yazawa Y, Saito T, Shimizu M, Kawashima H, Ae K, Matsumine A, Torigoe T, Sugiura H, Joyama S.

Int J Clin Oncol. 2016 Dec;21(6):1198. No abstract available.


Medullary metastasis of a malignant peripheral nerve sheath tumor: A case report.

Hagi T, Nakamura T, Yokoji A, Matsumine A, Sudo A.

Oncol Lett. 2016 Sep;12(3):1906-1908. Epub 2016 Jul 15.


Oncological outcome after lung metastasis in patients presenting with localized chondrosarcoma at extremities: Tokai Musculoskeletal Oncology Consortium study.

Nakamura T, Matsumine A, Yamada S, Tsukushi S, Kawanami K, Ohno T, Katagiri H, Sugiura H, Yamada K, Yamada Y, Sudo A, Nishida Y.

Onco Targets Ther. 2016 Jul 29;9:4747-51. doi: 10.2147/OTT.S107638. eCollection 2016.


Minimally invasive surgery using intraoperative electron-beam radiotherapy for the treatment of soft tissue sarcoma of the extremities with tendon involvement.

Matsumine A, Tsujii M, Nakamura T, Asanuma K, Matsubara T, Kakimoto T, Yada Y, Takada A, Ii N, Nomoto Y, Sudo A.

World J Surg Oncol. 2016 Aug 12;14(1):214. doi: 10.1186/s12957-016-0968-4.


Clinical outcome of recurrent giant cell tumor of the extremity in the era before molecular target therapy: the Japanese Musculoskeletal Oncology Group study.

Takeuchi A, Tsuchiya H, Ishii T, Nishida Y, Abe S, Matsumine A, Kawai A, Yoshimura K, Ueda T.

BMC Musculoskelet Disord. 2016 Jul 22;17:306. doi: 10.1186/s12891-016-1163-z.


Results of sub-analysis of a phase 2 study on trabectedin treatment for extraskeletal myxoid chondrosarcoma and mesenchymal chondrosarcoma.

Morioka H, Takahashi S, Araki N, Sugiura H, Ueda T, Takahashi M, Yonemoto T, Hiraga H, Hiruma T, Kunisada T, Matsumine A, Susa M, Nakayama R, Nishimoto K, Kikuta K, Horiuchi K, Kawai A.

BMC Cancer. 2016 Jul 14;16:479. doi: 10.1186/s12885-016-2511-y.


Teriparatide Treatment in Nursing Home Residents: A Retrospective Case-Control Study.

Niimi R, Kono T, Nishihara A, Hasegawa M, Matsumine A, Kono T, Sudo A.

J Am Geriatr Soc. 2016 Apr;64(4):911-2. doi: 10.1111/jgs.14073. No abstract available.


Endoscopic Versus Open Surgery for Calcaneal Bone Cysts: A Preliminary Report.

Nishimura A, Matsumine A, Kato K, Aasanuma K, Nakamura T, Fukuda A, Sudo A.

J Foot Ankle Surg. 2016 Jul-Aug;55(4):782-7. doi: 10.1053/j.jfas.2016.03.006. Epub 2016 Apr 8.


Impact of plasma fibrinogen levels in benign and malignant soft tissue tumors.

Asanuma K, Matsumine A, Nakamura T, Matsubara T, Asanuma Y, Oi T, Goto M, Okuno K, Kakimoto T, Yada Y, Sudo A.

Cancer Biomark. 2016;16(3):453-8. doi: 10.3233/CBM-160584.


The clinical outcome of pazopanib treatment in Japanese patients with relapsed soft tissue sarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study.

Nakamura T, Matsumine A, Kawai A, Araki N, Goto T, Yonemoto T, Sugiura H, Nishida Y, Hiraga H, Honoki K, Yasuda T, Boku S, Sudo A, Ueda T.

Cancer. 2016 May 1;122(9):1408-16. doi: 10.1002/cncr.29961. Epub 2016 Mar 11.

Supplemental Content

Loading ...
Support Center